超越结核病的进化:推出了针对慢性呼吸道疾病的新期刊
H D Blackbourn1, G B Migliori2
1International Union Against Tuberculosis and Lung Disease, Paris, France.
IJTLD open
|December 15, 2025
概括
一个新的开放获取期刊,IJTLD CRD,将专注于慢性呼吸系统疾病,如COPD和喘. 这旨在加速研究和治疗被忽视的慢性肺部疾病.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 公共卫生 公共卫生
背景情况:
- 慢性呼吸道疾病是全球重要的健康负担.
- 与传染病相比,慢性肺部疾病的研究相对被忽视.
- 现有的期刊往往专注于特定疾病,限制了跨疾病研究.
研究的目的:
- 宣布推出一个新的开放获取期刊,IJTLD CRD (国际结核病和肺病杂志 - 慢性呼吸道疾病).
- 为研究广泛的慢性呼吸道疾病提供专门的平台.
- 通过识别不同慢性肺部疾病的共同点,促进合作,加快治疗方法的开发.
主要方法:
- 该期刊将发表涵盖各种主题的开放获取文章.
- 关键领域包括结核病后的肺病,COPD,喘,空气污染的影响,与吸烟有关的肺损伤,支气管切除和职业肺病.
- 编辑的重点将鼓励研究突出共享的机制和潜在的治疗目标.
主要成果:
- 建立IJTLD CRD意味着致力于推进慢性呼吸道疾病领域的承诺.
- 该倡议旨在提高肺病学代表性不足的领域的可见性和研究成果.
- 该期刊将补充现有出版物,允许IJTLD和IJTLD Open专注于传染性呼吸道疾病.
结论:
- IJTLD CRD将成为慢性呼吸道疾病领域的研究人员,临床医生和政策制定者的重要资源.
- 通过整合研究,该期刊打算推动创新并改善患者的治疗结果.
- 这次推出解决了对专注于慢性肺部疾病的专用开放式访问平台的关键需求.
相关概念视频
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...